Drägerwerk AG & Co. KGaA, a leading provider of medical and safety technology, has demonstrated impressive growth over the past few months. Despite challenging market conditions, particularly in China, the company has achieved solid annual growth and continues to receive strong support from analysts.
Business Development
- Revenue and Profit: In the fiscal year 2024, Drägerwerk achieved revenue of nearly 3.4 billion euros, representing a currency-adjusted decline of 0.5 percent. However, earnings before interest and taxes (EBIT) rose by more than 16 percent to 194 million euros.
- Order Intake: The order intake was around 3.38 billion euros, above the previous year’s level. Especially, the safety technology segment recorded growth of 6.4 percent.
- Forecast: For the current year, Drägerwerk expects a currency-adjusted revenue increase of between 1 and 5 percent.
Dividend and Shareholder Structure
- Dividend: The board plans to propose a dividend of 1.97 euros per ordinary share and 2.03 euros per preferred share to the annual meeting. This represents an increase compared to the dividends of 2023, which were 1.74 euros and 1.80 euros, respectively.
- Equity Ratio: The equity ratio at the end of 2024 was 49.7 percent, which is above the target value of 40 percent.
Share Price and Market Development
- Share Price: The Drägerwerk shares have shown a positive development in recent months. On March 27, 2025, it reached a 52-week high of 65.10 euros.
- Annual Development: The stock recorded an annual development of over 20.77 percent, attributed to the innovative strength of the company.
- Analyst Recommendations: Analyst recommendations are predominantly positive, with an average price target of 69.20 euros.
Relevance for Private Investors
The positive developments at Drägerwerk offer private investors and small shareholders in the German-speaking region interesting investment opportunities. The combination of innovative technology, stable business development, and an attractive dividend policy makes the company a promising investment.
Conclusion
Drägerwerk presents itself as a solid company with a strong position in the medical and safety technology industry. Despite current market uncertainties, the company offers interesting perspectives for investors due to its innovative strength and positive business development.